These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-003429-95 A phase II, multicenter, non randomized, clinical study of Gemcitabine, ,Capecitabine and Sorafenib (BAY 43-9006) combination for the treatment of non resectable and/or metastatic patients with renal ... not-yet-due
Ongoing, reported early 2008-003554-14 “Estudio Clínico en Fase II aleatorizado de radioterapia, hormonoterapia y quimioterapia con docetaxel versus radioterapia y hormonoterapia, en pacientes afectados de cáncer de próstata localizado de ... not-yet-due
Ongoing 2009-014732-38 Ensayo clínico fase IV.II para el análisis de los factores moleculares de pronóstico de respuesta y beneficio clínico en pacientes con cáncer renal metastásico o avanzado, tratados con bevacizumab e i... not-yet-due
Completed, but no date 2011-001271-39 Estudio en fase II aleatorizado de vinflunina en monoterapia como terapia de mantenimiento en pacientes con cáncer avanzado o metastásico de células de transición del urotelio que obtengan beneficio c... bad-data
Completed, but no date Terminated 2011-002873-47 PHASE II CLINICAL TRIAL OF DOVITINIB (TKI-258) IN FIRST-LINE METASTATIC OR LOCALLY ADVANCED NON-RESECTABLE ADRENOCORTICAL CARCINOMA ENSAYO CLÍNICO FASE II DE DOVITINIB (TKI-258) EN PRIMERA LINEA DE... bad-data
Completed, but no date Terminated 2011-003498-27 A phase II open label study of cabazitaxel in patients with advanced or metastatic transitional cell carcinoma of the urothelium who have progressed ?12 months after a previous platinum based chemothe... bad-data
Completed, but no date, and reported results 2011-004627-12 Phase II Study of Weekly Cabazitaxel for Advanced Prostate Cancer in "Unfit" Hormone-Refractory Patients Previously Treated with Docetaxel. Ensayo Fase II de Cabazitaxel Semanal en Cancer de Prosta... bad-data
Reported results 2013-003811-23 Abirateriona acetate maintenance in combination with docetaxel after disease progression to abiraterona acetate in metastatic castration resistant prostate cancer. Randomized phase II study. Manten... 2020-06-08 due-trials
Completed, but no date, and reported results Terminated 2014-003127-22 Phase II study with pazopanib and weekly paclitaxel in metastatic or locally advanced squamous penile carcinoma patients previously treated with cisplatin based chemotherapy Estudio fase II de trat... bad-data
Reported results 2014-003192-28 Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS in response to enzalutamide in patients with metastatic CRPC no previously treated with chemotherapy Estudio fa... 2019-07-18 due-trials
Ongoing 2016-004011-12 Phase II study to evaluate efficacy and safety of sunitinib therapy in patients with metastatic renal clear cell carcinoma who have progressed to first-line immunotherapy treatment (INMUNOSUN Study) ... not-yet-due
Ongoing 2017-001469-26 Phase II trial evaluating olaparib maintenance in patients with MCRPC after docetaxel treatment reaching partial or stable response. Ensayo fase II para evaluar el tratamiento de mantenimiento con ... not-yet-due
Ongoing 2017-002765-22 Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer Impacto de la combinacion d... not-yet-due
Ongoing, reported early 2017-003159-44 Phase II trial of durvalumab (Medi4736) plus tremelimumab with concurrent radiotherapy in patients with localized muscle invasive bladder cancer treated with a selective bladder preservation approach ... not-yet-due
Completed, but no date 2017-004377-13 A multi-arm, multi-stage, randomized phase II/III trial of immunotherapy strategies in metastatic hormone-sensitive prostate cancer. Ensayo clínico aleatorizado, fase II/III, con múlt... bad-data
Ongoing 2018-004348-47 EFFICACY OF ATEZOLIZUMAB CONCURRENT WITH RADIOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER EFICACIA DEL ATEZOLIZUMAB CON RADIOTERAPIA CONCOMITANTE EN PACIENTES CON CÁNCER DE VEJIGA MÚSCU... not-yet-due
Ongoing, reported early 2019-001639-30 Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients: CABOMAYOR study Estudio piloto para evaluar eficacia, seguridad y tolerabilidad... not-yet-due
Not reported Terminated 2021-000943-30 Randomized phase II study evaluating the clinical utility of switching from prednisone to dexamethasone after initial biochemical progression in patients with hormone-sensitive metastatic prostate can... 2023-06-23 due-trials
Ongoing 2021-005364-22 Phase II non randomized clinical trial of NIVOLUMAB/IPILIMUMAB maintenance following first-line chemotherapy in unresectable locally advanced or metastatic urothelial cancer. Ensayo clínico de fase... not-yet-due
Other 2022-002586-15 A Phase 2, open-label, multi-centre, multi-national interventional trial to evaluate the efficacy and safety of erdafitinib (ERDA) monotherapy and erdafitinib (ERDA) and cetrelimab (CET) combination a... not-yet-due